Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors

Journal of Psychosocial Oncology

Volumn 27, Issue 4, 2009, Pages 415-434

  Reid Arndt, Stephanie A ^a   Yee, Albert ^b   Perry, Michael C ^a   Hsieh, Catherine ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b Atascadero State Hospital   (United States)

Author keywords

Breast cancer; Cognitive; Community integration; Quality of life; Social support

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMMUNITY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; FUNCTIONAL STATUS; HUMAN; LEISURE; MASTECTOMY; PARTIAL MASTECTOMY; PREDICTION; PRODUCTIVITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIAL STATUS; SOCIAL SUPPORT; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; SOCIAL ADJUSTMENT; SOCIAL SUPPORT; SURVIVAL; TREATMENT OUTCOME;

EID: 70449107616     PISSN: 07347332     EISSN: 15407586     Source Type: Journal    
DOI: 10.1080/07347330903183117     Document Type: Article

References (72)

1. Ahles, T. A., & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19, 812-820.
2. Ahles, T. A., Saykin, A., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
3. Ahles, T. A., Silberfarb, P. M., Herndon, J., Maurer, H., Kornblith, A. B., Aisner, J., et al. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group B. Journal of Clinical Oncology, 16, 1954-1960.
4. American Cancer Society. (2006). Facts and figures 2006. Available at www.cancer. org/downloads/STT/CAFF2006PWSecured.pdf.
5. Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: a metaanalysis and review of the literature. Journal of the International Neuropsychological Society, 9(7), 967-982.
6. Antoni, M. H., Lechner, S. C., Kazi, A., Wimberly, S. R., Sifre, T., Urcuyo, K. R., et al. (2006). How stress management improves quality of life after treatment for breast cancer. Journal of Consulting and Clinical Psychology, 74(6), 1143-1152.
7. Baker, F., Denniston, M., Zabora, J., Polland, A., & Dudley, W. N. (2002). A POMS short form for cancer patients: psychometric and structural evaluation. Psycho- Oncology, 11(4), 273-281.
8. Benton, A. L., & Hamsher, K. de S. (1989). Multilingual Aphasia Examination. Iowa City, IA: AJA Associates.
9. Bettencourt, B. A., & Sheldon, K. (2001). Social roles as mechanism for psychological need satisfaction within social groups. Journal of Personality and Social Psychology, 81(6), 1131-1143.
10. Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality of life instrument. Journal of Clinical Oncology, 15(3), 974-986. (Pubitemid 27106280)
11. Bradley, C. J., Neumark, D., Bednarek, H. L., & Schenk, M. (2005). Short-term effects of breast cancer on labor market attachment: Results from a longitudinal study. Journal of Health Economics, 24, 137-160.
12. Brezden, C. B., Phillips, K., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
13. Carver, C. S., Smith, R. G., Antoni, M. H., Petronis, V. M., Weiss, S., & Derhagopian, R. P. (2005). Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychology, 24(5), 508-516.
14. Carver, C. S., Smith, R. G., Petronis, V. M., & Antoni, M. H. (2006). Quality of life among long-term survivors of breast cancer: Different types of antecedents predict different classes of outcomes. Psycho-Oncology, 15(9), 749-758.
15. Corrigan, J. D., & Deming, R. (1995). Psychometric characteristics of the Community Integration Questionnaire: Replication and extension. Journal of Head Trauma Rehabilitation, 10, 41-53.
16. Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70.
17. Farmer, J. E., Clark, M. J., & Sherman, A. K. (2003). Rural versus urban social support seeking as a moderating variable in traumatic brain injury outcome. Journal of Head Trauma Rehabilitation, 18(2), 116-127.
18. Ferguson, R. J., Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., et al. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16(8), 772-777.
19. Figueiredo, M. I., Fries, E., & Ingram, K. M. (2004). The role of disclosure patterns and unsupportive social interactions in the well-being of breast cancer patients. Psycho-Oncology, 13, 96-105.
20. Freeman, J. R., & Broshek, D. K. (2002). Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer, 3(Suppl. 3), S91-S99.
21. Friedman, L. C., Kalidas, M., Elledge, R., Chang, J., Romero, C., Husain, I., et al. (2006). Optimism, social support and psychosocial functioning among women with breast cancer. Psycho-Oncology, 15, 595-603.
22. Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B., & Belin, T. R. (2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39-49.
23. Girard, D., Brown, J., Burnett-Stolnack, M., Hashimoto, N., Heir-Wellmer, S., Perlman, O. Q., et al. (1996). The relationship of neuropsychological status and productive outcomes following traumatic brain injury. Brain Injury, 10(9), 663-676.
24. Golden, C. J. (1978). Stroop color and word test. Chicago: Stoelting.
25. Griffin, S. L., Mindt, M. R., Rankin, E. J., Ritchie, A. J., & Scott, J. G. (2002). Estimating premorbid intelligence: comparison of traditional and contemporary methods across the intelligence continuum. Archives of Clinical Neuropsychology, 17(5), 497-507.
26. Hack, T. F., Degner, L. F., Watson, P., & Sinha, L. (2006). Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psycho-Oncology, 15, 9-19.
27. Hanks, R. A., Rapport, L. J., Millis, S. R., & Deshpande, S. A. (1999). Measures of executive functioning as predictors of functional ability and social integration in a rehabilitation sample. Archives of Physical Medicine and Rehabilitation, 80(9), 1030-1037.
28. Helgeson, V. S., & Tomich, P. L. (2005). Surviving cancer: A comparison of 5- year disease-free breast cancer survivors with healthy women. Psycho-Oncology, 14(4), 307-317.
29. Holland, K. D., & Hollahan, C. K. (2003). The relation of social support and coping to positive adaptation to breast cancer. Psychology and Health, 18, 15-29.
30. Johnstone, B., Callahan, C. D., Kapila, C. J., & Bouman, D. E. (1996). The comparability of the WRAT-R Reading Test and NAART as estimates of premorbid intelligence in neurologically impaired patients. Archives of Clinical Neuropsychology, 11(6), 513-519.
31. Johnstone, B., Hexum, C. L., & Ashkanazi, G. (1995). Extent of cognitive decline in traumatic brain injury based on estimates of premorbid intelligence. Brain Injury, 9(4), 377-384.
32. Kareken, D. A., Gur, R. C., & Saykin, A. J. (1995). Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: Comparison with the Barona formula. Archives of Clinical Neuropsychology, 10(2), 147-157.
33. Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
34. Main, D. S., Nowels, C. T., Cavender, T. A., Etschmaier, M., & Steiner, J. F. (2005). A qualitative study of work and work return in cancer survivors. Psycho-Oncology, 14, 992-1004.
35. Meyers, C. A., Byrne, K. S., & Komaki, R. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer, 12, 231-235.
36. Micelli, G., Caltagirone, C., Gainotti, G., Masullo, C., & Silveri, M. D. (1981). Neuropsychological correlated of localized cerebral lesions in nonaphasic braindamaged patients. Journal of Clinical Neuropsychology, 3, 53-63.
37. Minisini, A., Atalay, G., Bottomley, A., Puglisi, F., Piccart, M., & Biganzoli, L. (2004). What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncology, 5, 273-282.
38. Mols, F., Vingerhoets, A. J., Coebergh, J. W., & van de Poll-Franse, L. V. (2005). Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer, 41(17), 2613-2619.
39. National Cancer Institute. (2005). Dexmethylphenidate reduces some symptoms of chemobrain. Available at www.cancer.gov/clinicaltrials/results/ chemobrain0605/.
40. Neisser, U., Boodoo, G., Bouchard, T. J., Boykin, A. W., Brody, N., Ceci, S. J., et al. (1996). Intelligence: Knowns and unknowns. American Psychologist, 51, 77-101.
41. Osoba, D., Hsu, M.-A., Copley-Merriamn, C., Coombs, J., Johnson, F. R., Hauber, B., et al. (2006). Stated p of patients with cancer for health-related quality of life (HRQOL) domains during treatment. Quality of Life Research, 15, 273-283.
42. Posner, M. I., & Peterson, S. E. (1990). The attention system of the human brain. Annual Reviews in Neuroscience, 13, 25-42.
43. Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis II. Impact on employment and social functioning. Neurology, 41, 692-696.
44. Reid-Arndt, S. A. (2006). The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. NeuroRehabilitation, 21(1), 51-64.
45. Reitan, R. M. (1955). The relation of the trail making test to organic brain damage. Journal of Consulting Psychology, 16, 383-394.
46. Rugo, H. S., & Ahles, T. (2003). The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Seminars in Oncology, 30(6), 749-762.
47. Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapyinduced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8(4), 201-216.
48. Schagen, S. B., Van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
49. Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., et al. (2002). Late effects of adjuvant chemotherapy on cognitive function: a follow up study in breast cancer patients. Annals of Oncology, 13, 1387-1397.
50. Schou, I., Ekeberg, O., Sandvik, L., Hjermstad, M. J., & Ruland, C. M. (2005). Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up compared with the general population. Quality of Life Research, 14, 1813-1823.
51. Shacham, S. (1983). A shortened version of the Profile of Mood States. Journal of Personality Assessment, 47(3), 305-306.
52. Sheldon, K., & Bettencourt, B. A. (2002). Psychological need-satisfaction and subjective well-being within social groups. British Journal of Social Psychology, 41, 25-38.
53. Silberfarb, P. M., Philibert, D., & Levine, P. M. (1980). Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. American Journal of Psychiatry, 137, 597-601.
54. Spreen, O., & Strauss, E. (1991). A compendium of neuropsychological tests. New York: Oxford University Press.
55. Stanton, A., & Snider, P. (1993). Coping with a breast cancer diagnosis: A prospective study. Health Psychology, 12, 16-23.
56. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A metaanalysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychologist, 20, 76-89.
57. Stuss, D. T., Alexander, M. P., Hamer, L., Palumbo, C., Dempster, R., Binns, M., et al. (1998). The effects of focal anterior and posterior brain lesions on verbal fluency. Journal of the International Neuropsychological Society, 4, 265-278.
58. Talley, A. E., Molix, L., Schlegel, R. & Bettencourt, B. A. (in press). The influence of breast cancer survivors' perceived partner social support and need satisfaction on depressive symptoms: A longitudinal analysis. Psychology and Health.
59. Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2003). Cognitive impairment associated with chemotherapy for cancer: report of a workshop. Journal of Clinical Oncology, 22(11), 2233-2239.
60. Taylor, E. M. (1959). Psychological appraisal of children with cerebral deficits. Cambridge, MA: Harvard University Press.
61. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q., Hu, J., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
62. van Dam, F. S. A. M., Schagen, S. B., Muller, M. J., Boogerd, W., v.d. Wall, E., Fortuyn, M. E. D., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
63. Van Oosterhout, A. G. M., Ganzevles, P. G. J., Wilmink, J. T., De Geus, B. W. J., Van Vonderen, R. G. M. W., & Wijnstra, A. (1996). Sequelae in long-term survivors of small cell lung cancer. International Journal of Radiation Oncology, 34, 1037-1044.
64. Visser, M. R. M., & Smets, E. M. A. (1998). Fatigue, depression and quality of life in cancer patients: how are they related? Supportive Care in Cancer, 6, 101-108.
65. Wechsler, D. (1997a). WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation.
66. Wechsler, D. (1997b). WMS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation.
67. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer, 100(11), 2292-2299.
68. Weins, A. N., Bryan, J. E., & Crossen, J. R. (1993). Estimating WAIS-R FSIQ from National Adult Reading Test-Revised in normal subjects. Clinical Neuropsychologist, 7, 70-84.
69. Wenzel, L. B., Fairclough, D. L., Brady, M. J., Cella, D., Garrett, K. M., Kluhsman, B. C., et al. (1999). Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer, 86(9), 1768-1774. (Pubitemid 29513046)
70. Wieneke, M. H., & Dienst, E.R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 41, 61-66.
71. Wilkinson, G. S. (1993). Wide Range Achievement Test-Revision 3. Wilmington, DE: Jastak Association.
72. Willer, B., Rosenthal, M., Kreutzer, J. S., Gordon, W. A., & Rempel, R. (1993). Assessment of community integration following rehabilitation for traumatic brain injury. Journal of Head Trauma Rehabilitation, 8, 75-87.